Publications by authors named "Setareh Moghimi"

Claim this Profile
D
Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors.
Somayeh Salarinejad, Soheila Seyfi, Seiko Hayashi, Setareh Moghimi, Mahsa Toolabi

Mol Divers· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors.
Soheila Seyfi, Somayeh Salarinejad, Setareh Moghimi, Mahsa Toolabi, Nastaran Sadeghian

Arch Pharm (Weinheim)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies.
Mahfam Moradi, Alireza Mousavi, Zahra Emamgholipour, Johanna Giovannini, Setareh Moghimi

Eur J Med Chem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, α-Glucosidase inhibitory activity and docking studies of Novel Ethyl 1,2,3-triazol-4-ylmethylthio-5,6-diphenylpyridazine-4-carboxylate derivatives.
Loghman Firoozpour, Setareh Moghimi, Somayeh Salarinejad, Mahsa Toolabi, Mahdi Rafsanjani

BMC Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha pyrrolidinovalerophenone (α-PVP) administration impairs spatial learning and memory in rats through brain mitochondrial dysfunction.
Marzieh Noruzi, Homayoon Behmadi, Zahra Halvaei Khankahdani, Omid Sabzevari, Alireza Foroumadi, Setareh Moghimi

Toxicol Appl Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies.
Zaman Hasanvand, Tayebeh Oghabi Bakhshaiesh, Fariba Peytam, Loghman Firoozpour, Elaheh Hosseinzadeh, Setareh Moghimi

Bioorg Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thienopyrimidine-based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity.
Esmaeil Mohammadian, Tayebeh Oghabi Bakhshaiesh, Abolghasem Jouyban, Elahe Nazeri, Zaman Hasanvand, Setareh Moghimi

Arch Pharm (Weinheim)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug design strategies for the treatment azole-resistant candidiasis.
Setareh Moghimi, Mohammad Shafiei, Alireza Foroumadi

Expert Opin Drug Discov· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Zaman Hasanvand, Rasoul Motahari, Hamid Nadri, Setareh Moghimi, Roham Foroumadi

Front Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents.
Rasoul Motahari, Mohammad Amin Boshagh, Setareh Moghimi, Fariba Peytam, Zaman Hasanvand

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel 2-acetamide-5-phenylthio-1,3,4-thiadiazole-containing phenyl urea derivatives as potential VEGFR-2 inhibitors.
Mahsa Toolabi, Fatemeh Safari, Adileh Ayati, Parnian Fathi, Setareh Moghimi

Arch Pharm (Weinheim)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy.
Adileh Ayati, Setareh Moghimi, Mahsa Toolabi, Alireza Foroumadi

Eur J Med Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
Fariba Peytam, Ghazaleh Takalloobanafshi, Toktam Saadattalab, Maryam Norouzbahari, Zahra Emamgholipour, Setareh Moghimi

Sci Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.
Setareh Moghimi, Somayeh Salarinejad, Mahsa Toolabi, Loghman Firoozpour, Seyed Esmaeil Sadat Ebrahimi

Bioorg Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity.
Aram Faraji, Rasoul Motahari, Zaman Hasanvand, Tayebeh Oghabi Bakhshaiesh, Mahsa Toolabi, Setareh Moghimi

Bioorg Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors.
Loghman Firoozpour, Lixin Gao, Setareh Moghimi, Parvin Pasalar, Jamshid Davoodi

J Enzyme Inhib Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and radioligand-binding assay of 2,5-disubstituted thiadiazoles and evaluation of their anticonvulsant activities.
Mahsa Toolabi, Mona Khoramjouy, Ayoub Aghcheli, Adileh Ayati, Setareh Moghimi

Arch Pharm (Weinheim)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
Mehrdad Mehrazar, Mahdi Hassankalhori, Mahsa Toolabi, Fereshteh Goli, Setareh Moghimi

Mol Divers· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies.
Setareh Moghimi, Mahsa Toolabi, Somayeh Salarinejad, Loghman Firoozpour, Seyed Esmaeil Sadat Ebrahimi

Bioorg Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy.
Adileh Ayati, Setareh Moghimi, Somayeh Salarinejad, Maliheh Safavi, Behjat Pouramiri

Bioorg Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity.
Fariba Peytam, Mehdi Adib, Reihaneh Shourgeshty, Loghman Firoozpour, Mahmoud Rahmanian-Jazi, Setareh Moghimi

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies.
Mahsa Toolabi, Setareh Moghimi, Tayebeh Oghabi Bakhshaiesh, Somayeh Salarinejad, Ayoub Aghcheli

Eur J Med Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action.
Zahra Mojallal-Tabatabaei, Parham Foroumadi, Mahsa Toolabi, Fereshteh Goli, Setareh Moghimi

Bioorg Med Chem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiazole in the targeted anticancer drug discovery.
Adileh Ayati, Saeed Emami, Setareh Moghimi, Alireza Foroumadi

Future Med Chem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major.
Seyed Esmail Sadat-Ebrahimi, Maryam Mirmohammadi, Zahra Mojallal Tabatabaei, Marjan Azimzadeh Arani, Sogol Jafari-Ashtiani, Setareh Moghimi

Iran J Pharm Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis